| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/AOGS.13191 |
| P8608 | Fatcat ID | release_fllidjoxdbfdtkmrp46tr7itdy |
| P698 | PubMed publication ID | 28718198 |
| P50 | author | Katri Haimila | Q75231243 |
| Susanna Sainio | Q96068510 | ||
| P2093 | author name string | Anu Korhonen | |
| Inna Sareneva | |||
| Jarno Tuimala | |||
| Kati Sulin | |||
| Malla Kuosmanen | |||
| Suvi Natunen | |||
| P2860 | cites work | Presence of fetal DNA in maternal plasma and serum | Q57075132 |
| Routine antenatal anti-D prophylaxis in women who are Rh(D) negative: meta-analyses adjusted for differences in study design and quality | Q28732243 | ||
| Diagnostic accuracy of routine antenatal determination of fetal RHD status across gestation: population based cohort study | Q34132783 | ||
| Targeted routine antenatal anti-D prophylaxis in the prevention of RhD immunisation--outcome of a new antenatal screening and prevention program | Q34936608 | ||
| Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study | Q36538133 | ||
| Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation | Q37390911 | ||
| Sensitivity of fetal RHD screening for safe guidance of targeted anti-D immunoglobulin prophylaxis: prospective cohort study of a nationwide programme in the Netherlands | Q37397918 | ||
| Cost-effectiveness of first trimester non-invasive fetal RHD screening for targeted antenatal anti-D prophylaxis in RhD-negative pregnant women: a model-based analysis | Q38932336 | ||
| Diagnosis and treatment of severe hemolytic disease of the fetus and newborn: a 10-year nationwide retrospective study | Q41532753 | ||
| Report of the first nationally implemented clinical routine screening for fetal RHD in D- pregnant women to ascertain the requirement for antenatal RhD prophylaxis | Q46172895 | ||
| Routine noninvasive prenatal screening for fetal RHD in plasma of RhD-negative pregnant women-2 years of screening experience from Denmark. | Q46227317 | ||
| One single dose of 200 microg of antenatal RhIG halves the risk of anti-D immunization and hemolytic disease of the fetus and newborn in the next pregnancy | Q47683487 | ||
| Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy. | Q54301772 | ||
| P433 | issue | 10 | |
| P921 | main subject | Finland | Q33 |
| pregnant person | Q104720811 | ||
| P304 | page(s) | 1228-1233 | |
| P577 | publication date | 2017-07-17 | |
| P1433 | published in | Acta Obstetricia et Gynecologica Scandinavica | Q4676737 |
| P1476 | title | Targeted antenatal anti-D prophylaxis program for RhD-negative pregnant women - outcome of the first two years of a national program in Finland | |
| P478 | volume | 96 |
| Q98945760 | Introduction of Noninvasive Prenatal Testing for Blood Group and Platelet Antigens from Cell-Free Plasma DNA Using Digital PCR |
| Q102331644 | Prenatal RHD genotyping in Croatia: preliminary results |
| Q100413944 | RhIg for the prevention Rh immunization and IVIg for the treatment of affected neonates |
| Q89609735 | Rhesus D factor (RhD) negative women's experiences with pregnancy: An interpretive description |
| Q89599771 | Targeted antenatal anti-D prophylaxis for RhD-negative pregnant women: a systematic review |
| Q91872228 | Usefulness of Non-Invasive Fetal RHD Genotyping towards Immunoprophylaxis Optimization |
Search more.